Volume | 346,398 |
|
|||||
News | - | ||||||
Day High | 12.36 | Low High |
|||||
Day Low | 11.495 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Nevro Corp | NVRO | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
12.36 | 11.495 | 12.36 | 11.62 | 12.51 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,765 | 346,398 | $ 11.71 | $ 4,055,251 | - | 11.495 - 34.86 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:00:00 | 53,332 | $ 11.62 | USD |
Nevro Corp Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
423.31M | 36.40M | - | 425.17M | -92.21M | -2.53 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Nevro News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVRO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 12.27 | 13.30 | 11.495 | 12.39 | 459,281 | -0.65 | -5.30% |
1 Month | 14.40 | 14.70 | 11.495 | 12.89 | 427,770 | -2.78 | -19.31% |
3 Months | 16.68 | 17.75 | 11.495 | 14.62 | 454,388 | -5.06 | -30.34% |
6 Months | 15.66 | 22.64 | 11.495 | 16.76 | 538,667 | -4.04 | -25.80% |
1 Year | 33.62 | 34.86 | 11.495 | 19.77 | 532,278 | -22.00 | -65.44% |
3 Years | 166.37 | 182.45 | 11.495 | 55.50 | 545,452 | -154.75 | -93.02% |
5 Years | 61.13 | 188.14 | 11.495 | 75.98 | 489,623 | -49.51 | -80.99% |
Nevro Description
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. |